Relation between lipophilicity and pharmacological behavior of minocycline, doxycycline, tetracycline, and oxytetracycline in dogs.

Antimicrobial Agents and Chemotherapy
M BarzaL Weinstein

Abstract

Four tetracyclines were studied in dogs to determine the relation between their lipophilicity and various other pharmacological characteristics. Lipid solubility correlated inversely with the mean concentration of drug in arterial plasma and renal uptake and excretion, and directly with the biliary concentration gradient (level in bile/level of free drug in serum). Only the more lipophilic congeners minocycline and doxycycline passed the blood-brain and blood-ocular barriers in detectable concentrations. Mean levels of minocycline in the brain exceeded those of doxycycline by almost threefold; the difference was of borderline statistical significance (P = 0.05 to 0.1). Lipophilicity correlated inversely with the concentration of antibiotic in renal medulla but not in renal cortex or in the liver. When intestinal loops containing saline, milk, or 10% Gelusil were studied, the only combination exhibiting striking intraluminal accumulation was doxycycline in milk. These results indicate that lipophilicity correlates with many, but not all, of the transport characteristics of tetracycline antibiotics.

References

May 1, 1975·The Journal of Infectious Diseases·M BarzaL Weinstein
Sep 1, 1973·Clinical Pharmacology and Therapeutics·H MacdonaldL A Kanegis
Mar 1, 1968·The American Journal of the Medical Sciences·N H SteigbigelM Finland
Jun 1, 1971·The Journal of Pharmacy and Pharmacology·A Ryrfeldt
May 1, 1974·Kidney International·A WheltonJ R Bianchine
Jul 1, 1974·Clinical and Experimental Pharmacology & Physiology·S CarneyG Pattison
Jan 1, 1973·Journal of Pharmaceutical Sciences·C Hansch, J M Clayton
Jun 1, 1973·Journal of Pharmaceutical Sciences·R E Notari
Jan 1, 1973·Scandinavian Journal of Infectious Diseases·K Alestig
Jan 1, 1971·Chemotherapy·M Schach von Wittenau, T M Twomey
Jul 1, 1967·Toxicology and Applied Pharmacology·R G Kelly, L A Kanegis
May 1, 1968·The American Journal of the Medical Sciences·N H SteigbigelM Finland
Sep 1, 1969·Clinical Pharmacology and Therapeutics·J T Doluisio, L W Dittert
Oct 1, 1969·Journal of Pharmaceutical Sciences·J L Colaizzi, P R Klink
Jan 1, 1972·Chemotherapy·M Schach VON WITTENAUA C Swindell
Jan 1, 1968·Chemotherapy·M Schach von Wittenau
Jul 1, 1967·Toxicology and Applied Pharmacology·R G Kelly, L A Kanegis
Sep 1, 1954·The Journal of Pediatrics·S SCHWARZERA F ANDERSON
Mar 3, 1956·Nature·A ALBERT, C W REES
Nov 1, 1959·The Journal of Clinical Investigation·C M KUNINM FINLAND

❮ Previous
Next ❯

Citations

Jul 12, 2002·Journal of Neuroscience Research·Robert P Erickson, Ora Bernard
Dec 1, 1984·European Journal of Clinical Microbiology·W M Scheld
Jan 1, 1993·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·M Barza
Dec 12, 1983·Brain Research·K NonakaT Kotorii
Jan 1, 1991·Transactions of the Royal Society of Tropical Medicine and Hygiene·G D Overturf
Jan 1, 1981·Pharmacology & Therapeutics·J K Seydel, K J Schaper
Jan 1, 1986·International Journal of Immunopharmacology·J GletteC O Solberg
Jan 29, 2002·Toxicology in Vitro : an International Journal Published in Association with BIBRA·H Babich, D A Tipton
Jun 12, 2003·Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences·Milena Colovic, Silvio Caccia
Jan 18, 2007·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Lin ZhangKenji Hashimoto
Dec 23, 1998·Proceedings of the National Academy of Sciences of the United States of America·J YrjänheikkiJ Koistinaho
Mar 1, 1994·Avian Pathology : Journal of the W.V.P.A·A AnadonM A Martinez
Feb 15, 2000·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·L Dotevall, L Hagberg
Dec 1, 1990·Journal of Veterinary Pharmacology and Therapeutics·J L RiondJ E Riviere
Mar 5, 2009·Antimicrobial Agents and Chemotherapy·Chika IshikawaKiyofumi Yamanishi
Mar 1, 1984·Antimicrobial Agents and Chemotherapy·J GletteC O Solberg
Oct 1, 1984·Antimicrobial Agents and Chemotherapy·J GletteC O Solberg
Aug 1, 1985·Antimicrobial Agents and Chemotherapy·C W YimF T Fitzgerald
Jul 1, 1989·Antimicrobial Agents and Chemotherapy·L Dotevall, L Hagberg
May 1, 1990·Antimicrobial Agents and Chemotherapy·H R ChangJ C Pechère
Jul 2, 2010·American Journal of Physiology. Cell Physiology·Michael O GriffinFrancisco Villarreal
Jul 19, 2011·Neurology Research International·Chalonda R HandyThais Federici
Aug 4, 2012·Journal of Applied Oral Science : Revista FOB·Geisla Mary Silva SoaresMagda Feres
Dec 18, 2014·International Journal for Parasitology. Drugs and Drug Resistance·Kelly L JohnstonMark J Taylor
Apr 1, 1977·Antimicrobial Agents and Chemotherapy·W L FanningR A Sofferman
Dec 7, 2013·The International Journal of Neuroscience·Jacek KurzepaJoanna Bielewicz
Jan 1, 1993·Scandinavian Journal of Infectious Diseases·L HagbergJ Lindberg
Nov 4, 2009·Expert Review of Anti-infective Therapy·Timothy D Minniear, Steven C Buckingham
Apr 10, 2013·Journal of Pharmaceutical Sciences·Ji GuoDinesh V Patwardhan
Jul 31, 2013·The Veterinary Clinics of North America. Small Animal Practice·Mark G Papich
Sep 3, 2011·Pharmacological Research : the Official Journal of the Italian Pharmacological Society·Maria D Cuenca-LopezJoaquin Jordán
Aug 26, 2010·Food and Chemical Toxicology : an International Journal Published for the British Industrial Biological Research Association·A Y I El-GendiGehan M Kamel
Jun 16, 2009·Biochemical and Biophysical Research Communications·Jing Chen-RoetlingRaymond F Regan
Jan 6, 2006·Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism·Chanhung Z LeeWilliam L Young
Mar 25, 2008·Experimental Neurology·Radmila Filipovic, Nada Zecevic
Oct 18, 2007·Journal of the American Academy of Dermatology·Anneli Ririe Bowen, Timothy H McCalmont

❮ Previous
Next ❯

Related Concepts

Related Feeds

CRISPR Screens in Drug Resistance

CRISPR-Cas system enables the editing of genes to create or correct mutations. This feed focuses on the application of CRISPR-Cas system in high-throughput genome-wide screens to identify genes that may confer drug resistance.

Related Papers

Journal of Psychopharmacology
Raphael M Bonelli, Hans-Peter Kapfhammer
The British Journal of Venereal Diseases
M F Garner, J L Backhouse
Acta Psychiatrica Scandinavica
K Dewhurst
Journal of the American Veterinary Medical Association
Mark G PapichLisa A Fortier
© 2022 Meta ULC. All rights reserved